The long-term goal of this proposal is to elucidate the dynamic interactions that regulate early events in eukaryotic transcription initiation by RNA polymerase II. Assembly of the TFIIA-TFTID complex is an early step in preinitiation complex formation that can be modulated by interactions with numerous activators, coactivators, repressors, and corepressors. In this application I will emphasize the importance of the general transcription factor TFIIA as a promoter-selectivity factor, a modulator of TBP-interactions, and as a target of post-translational regulation. Evidence suggests that TFIIA has promoter-specific functions that are required for many, but not all RNA polymerase II transcription in vivo. The promoter sequences and cellular conditions that specify a requirement for one or another TFIIA function are not known. We propose to characterize promoter-specific functions of TFIIA using genomic array analysis of mechanistically defined TFIIA mutant alleles. TFIIA mutants have been characterized with defects in TBP-binding, TAFinteractions, NC2 derepression, DNA interactions, and phosphorylation acceptor sites. We will test these functionally different mutant alleles of TFIIA for genome-wide defects to identify specific promoters dependent upon these transcription activities. We will investigate the mechanistic basis for TFIIA promoter-specific functions using both in vivo and in vitro promoter-association assays. The role of TFIIA in regulating the recruitment of general transcription factors, TFIID TAFs, SAGA, the Mediator/SRB complex, and TBP-specific repressors will be investigated. We have also found that TFIIA phosphorylation can stimulate interactions with TBP and facilitate high level transcription in vivo. TFIID has been shown to be a candidate TFIIA kinase, and we propose to explore the regulatory function of TFIIA phosphorylation in the transcription cycle of several genes. Post-translational regulation of promoter core binding factors, like TFIIA and TBP, have not been investigated in significant detail. Although this grant focuses on the very specific questions regarding the role of TFIIA in core promoter recognition, we consider TFIIA to be central to many of the larger questions regarding the mechanisms of eukaryotic transcription activation and repression. Using genetic and biochemical approaches, this research proposal aims to elucidate novel mechanisms of transcription regulation and understand the complex interplay between promoter core binding factors and the coactivators and corepressors that regulate cell growth and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054687-07
Application #
6621923
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Tompkins, Laurie
Project Start
1996-08-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
7
Fiscal Year
2003
Total Cost
$304,642
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Wang, Pu; Day, Latasha; Lieberman, Paul M (2006) Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain. J Virol 80:10942-9
Wang, Pu; Day, Latasha; Dheekollu, Jayaraju et al. (2005) A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J Virol 79:13298-309
Chen, C J; Deng, Z; Kim, A Y et al. (2001) Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol Cell Biol 21:476-87
Deng, Z; Chen, C J; Zerby, D et al. (2001) Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation. J Virol 75:10334-47
Solow, S; Salunek, M; Ryan, R et al. (2001) Taf(II) 250 phosphorylates human transcription factor IIA on serine residues important for TBP binding and transcription activity. J Biol Chem 276:15886-92
Bell, P; Lieberman, P M; Maul, G G (2000) Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74:11800-10
Ozer, J; Moore, P A; Lieberman, P M (2000) A testis-specific transcription factor IIA (TFIIAtau) stimulates TATA-binding protein-DNA binding and transcription activation. J Biol Chem 275:122-8
Zerby, D; Chen, C J; Poon, E et al. (1999) The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol 19:1617-26
Moore, P A; Ozer, J; Salunek, M et al. (1999) A human TATA binding protein-related protein with altered DNA binding specificity inhibits transcription from multiple promoters and activators. Mol Cell Biol 19:7610-20
Solow, S P; Lezina, L; Lieberman, P M (1999) Phosphorylation of TFIIA stimulates TATA binding protein-TATA interaction and contributes to maximal transcription and viability in yeast. Mol Cell Biol 19:2846-52

Showing the most recent 10 out of 13 publications